GSK3B and melanoma: In recent years, AKT/GSK3β/β-catenin signaling axis plays an important role in inhibiting the proliferation, invasion, migration, improving immunogenicity and reducing drug resistance of melanoma (Abbas et al., 2024; Jere et al., 2019).